Antibe Therapeutics Inc(Pre-Merger) ATBPF

Very Nice Surprise

[markymark11]

I was predicting amalgamation news by May 17th, so I'm pleasantly surprised by this morning's announcement.

Also nice that the final share count will be lower than I was expecting. I was using 70-73 million shares post-amalgmation in my calculations, but it seems like it will be closer to 65 million shares.

[Actuarial]

It is a happy ending for retail investor with respect to amalgamation. And now my target price is $45 - $55 when a bought out deal. $15 - $25 when a partner deal. GLTA Longs!

[CandyC]

$45-50. Dreaming. I would expect $15 by year end after NASDAQ listed 

[Actuarial]

It depends on timeframe and what kind of deal Dan can bring to us. I personally prefer a bought deal though Dan mentioned partner deal is most likely.

[MrMugsy]

I agree. Timing on a potential acquisition will be out a little bit - but I agree it's possible. I think the patents will be hard for any Big Pharma to resist in the end. We just don't know what kind of surprises they have for us this summer - could really drive excitement - especially if they can announce some new drugs and a partnership in a smaller geography (or geographies).

[timber92]

Might be a dumb question but how do you calculate teh 65m shares? From the article it said they would issue just over 5m shares and currently there are about 45m out.. would it not be post amalgamation just over 50m shares? I might be missing something..

[Stoxxhp]

This post has been removed in accordance with Community Policy

[timber92]

Thanks! Missed that part.